Multi-drug-resistantSalmonella typhi—a need for therapeutic reappraisal
- 1 January 1992
- journal article
- other
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 12 (2) , 137-141
- https://doi.org/10.1080/02724936.1992.11747558
Abstract
Enteric fever caused by Salmonella typhi resistant to all the standard first-line antibiotics is emerging as a major problem in developing countries. Fifteen such culture-proven cases were treated with ceftriaxone (6), cefotaxime (5) or ciprofloxacin (4). The earliest defervescence occurred with ceftriaxone (mean 3.3 days). Clinical cures were obtained with all three drugs with only one child having a relapse. Ciprofloxacin, by virtue of its cost and an oral route of administration, is the ideal choice in a developing country.Keywords
This publication has 7 references indexed in Scilit:
- Treatment of multiresistant typhoid feverThe Lancet, 1991
- Comparative efficacies of aztreonam and chloramphenicol in children with typhoid feverThe Pediatric Infectious Disease Journal, 1990
- Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in childrenThe Pediatric Infectious Disease Journal, 1989
- CiprofloxacinDrugs, 1988
- Treatment of Typhoid Fever and Other Systemic Salmonelloses with Cefotaxime, Ceftriaxone, Cefoperazone, and Other Newer CephalosporinsClinical Infectious Diseases, 1987
- Chloramphenicol resistant salmonella typhi: Therapeutic considerationsIndian Journal of Pediatrics, 1984
- SALMONELLA TYPHI IN VIVO ACQUIRES RESISTANCE TO BOTH CHLORAMPHENICOL AND CO-TRIMOXAZOLEThe Lancet, 1981